WO2007053955A1 - Porous nanosheath networks, method of making and uses thereof - Google Patents
Porous nanosheath networks, method of making and uses thereof Download PDFInfo
- Publication number
- WO2007053955A1 WO2007053955A1 PCT/CA2006/001852 CA2006001852W WO2007053955A1 WO 2007053955 A1 WO2007053955 A1 WO 2007053955A1 CA 2006001852 W CA2006001852 W CA 2006001852W WO 2007053955 A1 WO2007053955 A1 WO 2007053955A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- porous material
- poly
- layers
- porous
- solid mass
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title description 2
- 239000011148 porous material Substances 0.000 claims abstract description 73
- 238000000034 method Methods 0.000 claims abstract description 51
- 239000000463 material Substances 0.000 claims abstract description 24
- 239000011800 void material Substances 0.000 claims abstract description 19
- 229920000642 polymer Polymers 0.000 claims abstract description 17
- 239000007787 solid Substances 0.000 claims abstract description 17
- 238000002156 mixing Methods 0.000 claims abstract description 9
- 239000011248 coating agent Substances 0.000 claims abstract description 3
- 238000000576 coating method Methods 0.000 claims abstract description 3
- 239000000155 melt Substances 0.000 claims abstract description 3
- 230000003362 replicative effect Effects 0.000 claims abstract description 3
- -1 poly(sodium 4-styrenesulfonate) Polymers 0.000 claims description 38
- 229920000371 poly(diallyldimethylammonium chloride) polymer Polymers 0.000 claims description 25
- 238000000605 extraction Methods 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 20
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 19
- 229940098773 bovine serum albumin Drugs 0.000 claims description 19
- 229920001610 polycaprolactone Polymers 0.000 claims description 19
- 238000000151 deposition Methods 0.000 claims description 18
- 239000000758 substrate Substances 0.000 claims description 14
- 239000002243 precursor Substances 0.000 claims description 12
- 238000000137 annealing Methods 0.000 claims description 10
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 238000000926 separation method Methods 0.000 claims description 5
- 238000006555 catalytic reaction Methods 0.000 claims description 4
- 238000013270 controlled release Methods 0.000 claims description 4
- 229920001464 poly(sodium 4-styrenesulfonate) Polymers 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 230000010261 cell growth Effects 0.000 claims description 2
- 238000004108 freeze drying Methods 0.000 claims description 2
- 239000007952 growth promoter Substances 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
- 125000003636 chemical group Chemical group 0.000 claims 1
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 31
- 229920001432 poly(L-lactide) Polymers 0.000 description 31
- 230000008021 deposition Effects 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 12
- 229920000867 polyelectrolyte Polymers 0.000 description 10
- 238000013459 approach Methods 0.000 description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 230000007423 decrease Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 238000010884 ion-beam technique Methods 0.000 description 3
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 3
- 239000003361 porogen Substances 0.000 description 3
- 238000001878 scanning electron micrograph Methods 0.000 description 3
- 238000001338 self-assembly Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 229920001059 synthetic polymer Polymers 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229920001940 conductive polymer Polymers 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000001493 electron microscopy Methods 0.000 description 2
- 238000007306 functionalization reaction Methods 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000002322 conducting polymer Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000001476 gene delivery Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229920000831 ionic polymer Polymers 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000010128 melt processing Methods 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 239000012229 microporous material Substances 0.000 description 1
- 239000002052 molecular layer Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920002959 polymer blend Polymers 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 238000002145 thermally induced phase separation Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D39/00—Filtering material for liquid or gaseous fluids
- B01D39/14—Other self-supporting filtering material ; Other filtering material
- B01D39/16—Other self-supporting filtering material ; Other filtering material of organic material, e.g. synthetic fibres
- B01D39/1669—Cellular material
- B01D39/1676—Cellular material of synthetic origin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/26—Synthetic macromolecular compounds
- B01J20/268—Polymers created by use of a template, e.g. molecularly imprinted polymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28054—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their surface properties or porosity
- B01J20/28095—Shape or type of pores, voids, channels, ducts
- B01J20/28097—Shape or type of pores, voids, channels, ducts being coated, filled or plugged with specific compounds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/305—Addition of material, later completely removed, e.g. as result of heat treatment, leaching or washing, e.g. for forming pores
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3202—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the carrier, support or substrate used for impregnation or coating
- B01J20/3206—Organic carriers, supports or substrates
- B01J20/3208—Polymeric carriers, supports or substrates
- B01J20/3212—Polymeric carriers, supports or substrates consisting of a polymer obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3268—Macromolecular compounds
- B01J20/327—Polymers obtained by reactions involving only carbon to carbon unsaturated bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3268—Macromolecular compounds
- B01J20/3272—Polymers obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3268—Macromolecular compounds
- B01J20/3272—Polymers obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds
- B01J20/3274—Proteins, nucleic acids, polysaccharides, antibodies or antigens
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3289—Coatings involving more than one layer of same or different nature
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/0061—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof characterized by the use of several polymeric components
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/26—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a solid phase from a macromolecular composition or article, e.g. leaching out
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2239/00—Aspects relating to filtering material for liquid or gaseous fluids
- B01D2239/10—Filtering material manufacturing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2220/00—Aspects relating to sorbent materials
- B01J2220/40—Aspects relating to the composition of sorbent or filter aid materials
- B01J2220/44—Materials comprising a mixture of organic materials
- B01J2220/445—Materials comprising a mixture of organic materials comprising a mixture of polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2201/00—Foams characterised by the foaming process
- C08J2201/04—Foams characterised by the foaming process characterised by the elimination of a liquid or solid component, e.g. precipitation, leaching out, evaporation
- C08J2201/046—Elimination of a polymeric phase
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2367/00—Characterised by the use of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Derivatives of such polymers
- C08J2367/02—Polyesters derived from dicarboxylic acids and dihydroxy compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2467/00—Characterised by the use of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Derivatives of such polymers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/249921—Web or sheet containing structurally defined element or component
- Y10T428/249953—Composite having voids in a component [e.g., porous, cellular, etc.]
Definitions
- the present invention relates to the field of porous materials.
- Porous polymeric materials with interconnected porosity are receiving great attention recently due to their wide range of potential applications.
- These potential applications touch various fields such as: biomedical and pharmaceutical applications [tissue engineering, extracorporeal devices such as those that are connected to the body to assist in surgery or dialysis, implantable medical devices that serve for example as substitutes for blood vessels, intra-ocular lenses, bio-sensing electrodes, catheters, and drug and gene delivery (for example as substrate for controlled release)], materials for chromatographic and other separation techniques (such as filtration, dialysis and osmosis), materials for diagnostic devices such as lateral flow devices, flow through devices and other immunoassay devices , catalysis of chemical and biochemical reactions, materials for conductivity applications and the list goes on.
- biomedical and pharmaceutical applications tissue engineering, extracorporeal devices such as those that are connected to the body to assist in surgery or dialysis, implantable medical devices that serve for example as substitutes for blood vessels, intra-ocular lenses, bio-sensing electrodes, catheters,
- porous materials have particular use as polymeric scaffolding for cell tissue engineering. Interconnectivity of the pore network is essential for tissue ingrowth, vascularization and diffusion of nutrients. Controlled pore size distribution and large void volumes are other important features.
- biodegrable polymers such as poly(alpha esters) such as poly(lactic acid), poly(glycolic acid) and their copolymers. Such materials are approved for human clinical use in many jurisdictions.
- LBL deposition is a simple and effective approach to deposit ultrathin and uniformly assembled molecular layers on surfaces (refs 11 and 12).
- polyelectrolytes are adsorbed on an oppositely charged surface, reversing the surface charge and leaving it primed for the next deposition cycle (refs 13 and 14).
- the resulting structure is multilayered with each molecular layer composed of oppositely charged polyelectrolyt.es.
- each layer can be closely controlled through the salinity of the polyelectrolyte solution (refs 13 and 14), the quality of the solvent (ref 15) and the charge density on the polyion chain (ref 16). Deposition time, polyelectrolyte concentration and molecular weight are known to be less important parameters (ref 12). Originally exclusively investigated on macroscopically flat surfaces, this technique has been recently used to fabricate hollow spheres by assembling multilayered films onto colloidal particles and subsequently removing the core (refs 17 and 18).
- the present invention provides a method for making a porous material and the material produced thereof. This method comprising the steps of:
- melt-blending two or more non-miscible polymers for example poly(L-lactic acid) and poly( ⁇ -caprolactone), to obtain a co-continuous melt;
- step (b) solidifying the melt of step (a) to obtain a solid mass
- the alternating layers can optionally be polymeric layers. Also, this method can optionally further comprise, after step (b), a quiescent annealing of the solid mass obtained. It can also further comprise, after step (c), the step of depositing one or more precursor layers on the internal surface of said pore network. This method can also further comprise, after step (e), the step of exchanging the solvent and freeze-drying the porous material.
- the present invention also provides novel porous materials having a void fraction higher than about 75% and mainly consisting of essentially fully interconnected sheath-like non-spherical pores and essentially non-fibrous walls.
- these materials will have a void fraction higher than 90%. More preferably, these materials will have a void fraction ranging from 98.7% to 99.6%.
- these materials will exhibit average pore wall thickness of about 100 nanometers, a specific surface area of about 0.4 to about 140 m 2 /gram or an internal surface area per unit volume of about 0.29 to about 2.3 ⁇ m "1 for pore diameters ranging from 1.8 to 6.4 ⁇ m.
- This invention also relates to the use of the porous materials of the present invention in tissue engineering, as a substrate for controlled release applications and as an implantable medical device.
- polymer is meant to refer to naturally occurring or synthetic organic compounds of relatively high molecular weight comprising several linked units.
- examples of polymers are, without being so limited, poly(diallyldimethylammonium chloride), poly(sodium 4- styrenesulfonate), poly(L-lactic acid), poly( ⁇ -caprolactone), bovine serum albumin, and proteins.
- layers and “polymeric layers” are meant to refer to layers of molecules that, in the case of polymeric layers, comprise at least one polymer. These layers can comprise a variety of small molecules as well as macromolecular assemblies to such as cells. Notably, these layers can comprise, without being so limited, synthetic polymers, polyelectrolytes proteins, cell growth promoters, and functionalizing agents.
- the term “functionalizing agent” is meant to refer to an agent that can provide some chemical functionality.
- Figure 1 is a schematic stepwise illustration of the method of the present invention for fabricating porous polymer/protein nanosheath networks
- Figure 2 shows the percentage of mass increase as a function of the number of PDADMAC/BSA layers assembled onto the internal surface of porous PLLA templates, ( ⁇ ; average pore size 1.4 ⁇ m and ⁇ ; average pore size 6.3 ⁇ m);
- FIG. 3 depicts scanning electron micrographs of microstructures of series ⁇ (A, C, E) and ⁇ (B, D, F).
- Micrographs (A) and (B) represent the morphologies of the porous structures obtained after melt- blending and extraction of the PCL porogen phase (Stage B, Fig. 1 );
- Photos (C) and (D) are taken after LBL deposition onto the PLLA porous template and extraction of the PLLA phase (Stage D, Fig. 1 );
- photo (E) is taken after LBL deposition and partial extraction of the PLLA;
- photo (F) shows a typical sheath thickness of about 100 nm in the final porous structure ( ⁇ ) after deposition of 4 PDADMAC/BSA bilayers.
- the porous structures were prepared using a focused ion beam (FIB) apparatus (ref 19) to minimize macroscopic deformation or collapse of the structure;
- FIB focused ion beam
- Figure 4 shows the properties of the structures produced at each stage of the preparation process and corresponding scanning electron micrographs of series ⁇ . Similar photomicrographs were obtained for series a.
- the present invention provides new porous materials and a method for making these high void volume materials.
- the method comprises LBL deposition on a porous co-continuous blend template followed by selective extraction of the template.
- a clear advantage of the present method of prior art advances is the capability of close control over a wide range of pore size and void volume (up to 99.6%), combined with an interconnectivity of the pores network of 100%. Also, the use of the LBL deposition approach allows for an easy and straightforward functionalization of the structure by incorporating into the process bio- or chemically-active molecules, conducting polymers, functionalizing agents, etc.
- the first step of the method is the blending of co-continuous synthetic polymer blends such as blends of poly(L- lactic acid) (PLLA) and poly( ⁇ -caprolactone) (PCL), referred to as PLLA/PCL blends, via melt processing.
- PLLA poly(L- lactic acid)
- PCL poly( ⁇ -caprolactone)
- PLLA/PCL blends were prepared by melt-mixing in a Haake internal mixer at 200°C and 50 rpm for 5 min. The blends were then quenched under liquid nitrogen to freeze-in the morphology. Depending on the protocol used, the annealing of the blends was carried out at the blend preparation temperature on a hot plate press without applied pressure for 2 hours.
- the PLLA material was replicated (coated) by consecutively assembling polymer and protein by LBL deposition techniques onto the porous template. [0028] More precisely, three precursor layers (PDADMAC/
- PSS/PDADMAC PSS/PDADMAC
- PDADMAC poly(diallyldimethylammonium chloride)
- PSS poly(sodium 4-styrenesulfonate)
- a vacuum/pressure cycle was used to force the penetration of the solution inside the hydrophobic PLLA templates.
- Polyelectrolytes were allowed to adsorb for 4 hours at room temperature. The samples were then washed for 4 hours in pure water under constant agitation.
- PLLA template subsequent selective extraction of the PLLA leaves behind a network of nano-scale cylindrical sheaths.
- sheaths composed solely of the self-assembled layers, when examined by electron microscopy, after a focused ion beam preparation approach (ref 19) were shown to possess a pore size similar to the original PLLA phase size, which was confirmed by BET measurements.
- the typical sheath thickness is in the 100 nm range.
- Precise pore sizes and narrow size distribution patterns may be achieved via controlling the pore size obtained by selective extraction of the co-continuous synthetic polymer blend. Indeed, it has been shown that pore sizes may be controlled over three orders of magnitude using quiescent annealing, (refs 7-10).
- ⁇ refers to samples produced with the as-melt-blended material and ⁇ to samples obtained with material that was subject to quiescent annealing for 2 hours after the mixing stage. This latter operation caused an increase of the average size of the PCL continuous phase from 1.4 to 6.3 microns as determined from the internal surface area measurements using BET N 2 adsorption technique.
- Subsequent preparation of the porous substrate demonstrates that this pore size is maintained in the final material.
- the first stage is the preparation of co-continuous PLLA/PCL 50/50 %wt. structures via melt blending. Gravimetric measurements show that the continuity of the PCL phase in the original PLLA/PCL blend is 96.2% for system ⁇ and 94.1 % for system ⁇ . This clearly confirms the formation of co-continuous microstructures.
- the uncharged fully continuous PLLA surface is then used as a template for the self assembly of PDADMAC and bovine serum albumin (BSA).
- BSA bovine serum albumin
- the first PDADMAC layer adsorbs readily onto the hydrophobic PLLA surface and attaches at the interface via secondary and hydrophobic interactions (ref 22).
- PDADMAC/PSS/BSA 10 layer assembly is provided by gravimetric measurements.
- a constant mass of each species is deposited throughout the process; however, BSA adsorbs proportionally in greater quantity compared to the polyelectrolytes because of its globular conformation which allows for the formation of a more densely packed and thicker layer (refs 21 and 23).
- the amount adsorbed in a particular step is highly uniform.
- the variation between the two preparation protocols is, as mentioned earlier, the result of the annealing process which increases the phase size of ⁇ causing a decrease of the interfacial surface area and, therefore the adsorbed amount.
- the surface loading for BSA on PDADMAC surface was calculated by dividing the average amount of BSA adsorbed per deposition cycle (obtained from Fig. 2) by the internal surface area of the PLLA porous templates.
- samples ⁇ are advantageously performed in methylene chloride. Porous and partially transparent structures without deformation or cracking are obtained. Substrate ⁇ is best extracted in a mixture of methylene chloride/ethanol. Gravimetric measurements show that virtually no residual PLLA is left in samples ⁇ after extraction while in the case of samples ⁇ , 0.4% of the initial mass of PLLA is still present.
- Figure 3 demonstrates the morphology of both series through the preparation procedure.
- the effect of annealing ( ⁇ ) on the pore diameter after PCL extraction (Stage B) is illustrated in Figs. 3A and 3B.
- Figs. 3C and 3D After LBL deposition and extraction of the PLLA (Figs. 3C and 3D), it can be seen that the pore size of the porous materials is similar to the phase size in the corresponding blend template.
- the microstructure generated is the replicate of the interface of the initial co-continuous polymer blend.
- FIG. 3E Materials with significantly thicker walls, and hence better mechanical properties, are obtained by leaving a portion of the PLLA layer as an additional support of the final structure. This approach may also serve to control the void volume fraction of the network.
- a sheath longitudinal and cross section is clearly visible in Fig. 3E while Fig. 3F illustrates a typical nanosheath thickness of about 100 nm for substrate ⁇ . It is particularly clear on this figure that the nanosheaths are not fibrous. Indeed, it is clear on Figures 3D and 3F that the nanosheaths are not fibrous-like.
- Figure 4 shows the properties of the structures for ⁇ and ⁇ at each stage of the process. The overall shape and approximate dimensions of the samples are preserved at any point of the procedure. The radial marks observed on the outer skin of the substrates are artifacts generated by the knife during the initial shaping process but are not present in the internal morphology.
- stage B After stage B, the effect of annealing of the initial PLLA/PCL blend on the pore size can be seen.
- the phase growth observed during annealing decreases the interfacial surface area of the co-continuous blend and thus decreases the internal surface area available for deposition.
- the assembled polyelectrolyte/protein layers take the form of very thin sheaths.
- One of the main advantages of the method of the present invention is that deposition of self-assembled multilayers onto a PLLA template surface and subsequent extraction of that surface should yield a structure with twice the surface area per unit volume of the original porous blend.
- substrate ⁇ possesses a void fraction of 98.7%, an internal surface area per unit volume of 2.3 ⁇ rr ⁇ 1 and a specific surface area of 140 m 2 g "1 while the annealed substrate ⁇ yields a void fraction of 99.6%, an internal surface area of 0.63 ⁇ m "1 and a specific surface area of 63 m 2 g "1 .
- FIG. 19 (FIB) apparatus (ref 19) was used to prepare the porous materials for electron microscopy. This approach minimizes macroscopic deformation or collapse of the structure.
- the method of the present invention is very versatile and high levels of control can be exercised over void fraction, surface area and pore size.
- any polymer pair can be used to prepare the original co-continuous blend template. This potentially allows one to prepare such porous structures with pore sizes ranging from 100 nm to hundreds of microns.
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Animal Behavior & Ethology (AREA)
- Thermal Sciences (AREA)
- Physics & Mathematics (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
- Materials For Medical Uses (AREA)
Abstract
The present invention relates to a method for making a porous material, comprising the steps of (I) melt-blending two or more non-miscible polymers to obtain a co-continuous melt, (II) solidifying the melt to obtain a solid mass consisting of two co-continuous polymer phases, (III) selectively extracting one of the co-continuous phases thereby creating within the solid mass an essentially continuous pore network having an internal surface, (iv) replicating the internal surface of the pore network within the solid mass by coating the internal surface with successive layers of materials, and (v) selectively extracting the solid mass without extracting the layers of materials, to thereby yield the product porous material, formed of the layers of materials, having a void fraction higher than about 75%, and mainly consisting of essentially fully interconnected sheath-like non-spherical pores and essentially non-fibrous walls.
Description
TITLE OF THE INVENTION
[0001] Porous Nanosheath Networks, Method of Making and Uses
Thereof.
FIELD OF THE INVENTION
[0002] The present invention relates to the field of porous materials.
BACKGROUND OF THE INVENTION
[0003] Porous polymeric materials with interconnected porosity are receiving great attention recently due to their wide range of potential applications. These potential applications touch various fields such as: biomedical and pharmaceutical applications [tissue engineering, extracorporeal devices such as those that are connected to the body to assist in surgery or dialysis, implantable medical devices that serve for example as substitutes for blood vessels, intra-ocular lenses, bio-sensing electrodes, catheters, and drug and gene delivery (for example as substrate for controlled release)], materials for chromatographic and other separation techniques (such as filtration, dialysis and osmosis), materials for diagnostic devices such as lateral flow devices, flow through devices and other immunoassay devices , catalysis of chemical and biochemical reactions, materials for conductivity applications and the list goes on.
[0004] In the sphere of tissue engineering, porous materials have particular use as polymeric scaffolding for cell tissue engineering. Interconnectivity of the pore network is essential for tissue ingrowth, vascularization and diffusion of nutrients. Controlled pore size distribution and large void volumes are other important features.
[0005] Much scientific effort is focused on biodegrable polymers such as poly(alpha esters) such as poly(lactic acid), poly(glycolic acid) and their copolymers. Such materials are approved for human clinical use in many jurisdictions.
[0006] Five different techniques to fabricate interconnected porous polymeric substrates for tissue engineering applications have been developed: textile process (ref 1), particulate leaching (ref 2), gas foaming (ref 3), thermally induced phase separation (refs 4 and 5) and hydrogel cross- linking (ref 6). However, every one of these approaches suffers from severe limitations including: low levels of interconnectivity; low void volume; structural fragility; difficulties in functionalization; poor control of pore size and distribution; and difficulties in obtaining reproducible porosities and large 3D articles.
[0007] Recently, an approach to preparing microporous materials, based on the melt-blending of two immiscible polymers, has been described (refs 7-10). It was shown that selective extraction of one of two components in a co-continuous structure can result in a single component structure of fully interconnected porosity with finely controlled pore size, porosity and morphology. This technique can generate porosities with high surface areas and pore diameters ranging from as low as about 100 nanometers upwards to hundreds of microns (refs 8-10). On the other hand this approach is limited in the void volume that can be attained and it can be used to prepare only relatively low void volume substrates (75%).
[0008] In an entirely different field of scientific activity, self- assembly via layer-by-layer (LBL) deposition is gaining significant attention. LBL deposition is a simple and effective approach to deposit ultrathin and uniformly assembled molecular layers on surfaces (refs 11 and 12). In that approach, polyelectrolytes are adsorbed on an oppositely charged surface,
reversing the surface charge and leaving it primed for the next deposition cycle (refs 13 and 14). The resulting structure is multilayered with each molecular layer composed of oppositely charged polyelectrolyt.es. The thickness of each layer can be closely controlled through the salinity of the polyelectrolyte solution (refs 13 and 14), the quality of the solvent (ref 15) and the charge density on the polyion chain (ref 16). Deposition time, polyelectrolyte concentration and molecular weight are known to be less important parameters (ref 12). Originally exclusively investigated on macroscopically flat surfaces, this technique has been recently used to fabricate hollow spheres by assembling multilayered films onto colloidal particles and subsequently removing the core (refs 17 and 18).
[0009] To date, however, no work has been reported on the use of
LBL techniques to create 3-dimensional, fully interconnected substrates.
SUMMARY OF THE INVENTION
[0010] The present invention provides a method for making a porous material and the material produced thereof. This method comprising the steps of:
(a) melt-blending two or more non-miscible polymers, for example poly(L-lactic acid) and poly(ε-caprolactone), to obtain a co-continuous melt;
(b) solidifying the melt of step (a) to obtain a solid mass;
(c) selectively extracting at least one of the polymers from the solid mass, thereby creating an essentially
continuous pore network within the solid mass, said pore network having an internal surface;
(d) replicating the internal surface of the pore network within the solid mass by coating said internal surface with successive layers; and
(e) selectively extracting the solid mass without extracting the layers, thereby producing a porous material, this extraction being complete or partial depending on the desired mechanical properties of the resulting material;
[0011] In this method, the alternating layers can optionally be polymeric layers. Also, this method can optionally further comprise, after step (b), a quiescent annealing of the solid mass obtained. It can also further comprise, after step (c), the step of depositing one or more precursor layers on the internal surface of said pore network. This method can also further comprise, after step (e), the step of exchanging the solvent and freeze-drying the porous material.
[0012] The present invention also provides novel porous materials having a void fraction higher than about 75% and mainly consisting of essentially fully interconnected sheath-like non-spherical pores and essentially non-fibrous walls. Preferably, these materials will have a void fraction higher than 90%. More preferably, these materials will have a void fraction ranging from 98.7% to 99.6%. Preferably, these materials will exhibit average pore wall thickness of about 100 nanometers, a specific surface area of about 0.4 to about 140 m2/gram or an internal surface area per unit volume of about 0.29 to about 2.3 μm"1 for pore diameters ranging from 1.8 to 6.4 μm.
[0013] This invention also relates to the use of the porous materials of the present invention in tissue engineering, as a substrate for controlled release applications and as an implantable medical device.
[0014] Herein, the term "polymer" is meant to refer to naturally occurring or synthetic organic compounds of relatively high molecular weight comprising several linked units. Examples of polymers are, without being so limited, poly(diallyldimethylammonium chloride), poly(sodium 4- styrenesulfonate), poly(L-lactic acid), poly(ε-caprolactone), bovine serum albumin, and proteins.
[0015] Herein, the terms "layers" and "polymeric layers" are meant to refer to layers of molecules that, in the case of polymeric layers, comprise at least one polymer. These layers can comprise a variety of small molecules as well as macromolecular assemblies to such as cells. Notably, these layers can comprise, without being so limited, synthetic polymers, polyelectrolytes proteins, cell growth promoters, and functionalizing agents.
[0016] Herein, the term "functionalizing agent" is meant to refer to an agent that can provide some chemical functionality.
[0017] Other objects, advantages and features of the present invention will become more apparent to a person skilled in the art to which they pertain upon reading of the following non-restrictive description of specific embodiments thereof, given by way of example only with reference to the accompanying drawings.
DESCRIPTION OF THE DRAWINGS
[0018] Figure 1 is a schematic stepwise illustration of the method of the present invention for fabricating porous polymer/protein nanosheath networks;
[0019] Figure 2 shows the percentage of mass increase as a function of the number of PDADMAC/BSA layers assembled onto the internal surface of porous PLLA templates, (α; average pore size 1.4 μm and β; average pore size 6.3 μm);
[0020] Figure 3 depicts scanning electron micrographs of microstructures of series α (A, C, E) and β (B, D, F). Micrographs (A) and (B) represent the morphologies of the porous structures obtained after melt- blending and extraction of the PCL porogen phase (Stage B, Fig. 1 ); Photos (C) and (D) are taken after LBL deposition onto the PLLA porous template and extraction of the PLLA phase (Stage D, Fig. 1 ); photo (E) is taken after LBL deposition and partial extraction of the PLLA; and photo (F) shows a typical sheath thickness of about 100 nm in the final porous structure (β) after deposition of 4 PDADMAC/BSA bilayers. The porous structures were prepared using a focused ion beam (FIB) apparatus (ref 19) to minimize macroscopic deformation or collapse of the structure;
[0021] Figure 4 shows the properties of the structures produced at each stage of the preparation process and corresponding scanning electron micrographs of series β. Similar photomicrographs were obtained for series a.
DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS
[0022] The present invention provides new porous materials and a method for making these high void volume materials. The method comprises
LBL deposition on a porous co-continuous blend template followed by selective extraction of the template.
[0023] A clear advantage of the present method of prior art advances is the capability of close control over a wide range of pore size and void volume (up to 99.6%), combined with an interconnectivity of the pores network of 100%. Also, the use of the LBL deposition approach allows for an easy and straightforward functionalization of the structure by incorporating into the process bio- or chemically-active molecules, conducting polymers, functionalizing agents, etc.
[0024] Turning now to Fig. 1 , the first step of the method is the blending of co-continuous synthetic polymer blends such as blends of poly(L- lactic acid) (PLLA) and poly(ε-caprolactone) (PCL), referred to as PLLA/PCL blends, via melt processing.
[0025] PLLA/PCL blends were prepared by melt-mixing in a Haake internal mixer at 200°C and 50 rpm for 5 min. The blends were then quenched under liquid nitrogen to freeze-in the morphology. Depending on the protocol used, the annealing of the blends was carried out at the blend preparation temperature on a hot plate press without applied pressure for 2 hours.
[0026] Selective extraction of the PCL porogen phase in, for example acetic acid, yields a fully interconnected, highly continuous porous PLLA material.
[0027] The PLLA material was replicated (coated) by consecutively assembling polymer and protein by LBL deposition techniques onto the porous template.
[0028] More precisely, three precursor layers (PDADMAC/
PSS/PDADMAC) were initially deposited to provide a uniformly charged surface and facilitate subsequent protein adsorption. The precursor film was formed by the alternate adsorption of PDADMAC [poly(diallyldimethylammonium chloride)] and PSS [poly(sodium 4-styrenesulfonate)] from aqueous solutions containing 10 mg ml"1 of polyelectrolytes and 1 M NaCI. A vacuum/pressure cycle was used to force the penetration of the solution inside the hydrophobic PLLA templates. Polyelectrolytes were allowed to adsorb for 4 hours at room temperature. The samples were then washed for 4 hours in pure water under constant agitation. Using the same procedure, (BSA/PDADMAC)n/BSA multilayers were deposited from 10 mg ml'1 BSA [bovine serum albumin] solution in PBS (pH = 7.0) (refs 20 and 21).
[0029] After deposition of the assembled molecular layers on the
PLLA template, subsequent selective extraction of the PLLA leaves behind a network of nano-scale cylindrical sheaths.
[0030] These sheaths, composed solely of the self-assembled layers, when examined by electron microscopy, after a focused ion beam preparation approach (ref 19) were shown to possess a pore size similar to the original PLLA phase size, which was confirmed by BET measurements.
[0031] The typical sheath thickness is in the 100 nm range.
[0032] Precise pore sizes and narrow size distribution patterns may be achieved via controlling the pore size obtained by selective extraction of the co-continuous synthetic polymer blend. Indeed, it has been shown that pore sizes may be controlled over three orders of magnitude using quiescent annealing, (refs 7-10).
[0033] In order to demonstrate the preparation of materials of different pore sizes, two preparation protocols were used. The indication α refers to samples produced with the as-melt-blended material and β to samples obtained with material that was subject to quiescent annealing for 2 hours after the mixing stage. This latter operation caused an increase of the average size of the PCL continuous phase from 1.4 to 6.3 microns as determined from the internal surface area measurements using BET N2 adsorption technique. Subsequent preparation of the porous substrate demonstrates that this pore size is maintained in the final material.
[0034] Still referring to Fig. 1 , a detailed description of the method of preparation of the present invention now follows. The first stage is the preparation of co-continuous PLLA/PCL 50/50 %wt. structures via melt blending. Gravimetric measurements show that the continuity of the PCL phase in the original PLLA/PCL blend is 96.2% for system α and 94.1 % for system β. This clearly confirms the formation of co-continuous microstructures.
[0035] This co-continuous morphology is preserved during the subsequent annealing process for substrate β; only 2.1% of the continuity of the PCL phase is lost. The extraction of the PCL porogen phase yields a fully interconnected porous PLLA network of about 50% void volume. A small fraction of the PCL phase (3.8% and 5.9% of the weight of the initial PCL composition for Systems α and β respectively) remains imprisoned within the PLLA phase in the form of small segregated droplets. As anticipated, the internal surface area decreases in the case of the annealed structures β due to the increased phase size.
[0036] The uncharged fully continuous PLLA surface is then used as a template for the self assembly of PDADMAC and bovine serum albumin (BSA). The first PDADMAC layer adsorbs readily onto the hydrophobic PLLA
surface and attaches at the interface via secondary and hydrophobic interactions (ref 22).
[0037] Turning now to Fig. 2, evidence for the
PDADMAC/PSS/BSA 10 layer assembly is provided by gravimetric measurements. A constant mass of each species is deposited throughout the process; however, BSA adsorbs proportionally in greater quantity compared to the polyelectrolytes because of its globular conformation which allows for the formation of a more densely packed and thicker layer (refs 21 and 23). In all cases the amount adsorbed in a particular step is highly uniform. The variation between the two preparation protocols is, as mentioned earlier, the result of the annealing process which increases the phase size of β causing a decrease of the interfacial surface area and, therefore the adsorbed amount. Indeed, the ratio of the mass of BSA adsorbed onto the PDADMAC surface (α/β), ηmass = 3.7, reasonably correlates with the ratio of the internal surface areas (α/β) ηSUrf = 4.4.
[0038] The surface loading measurements for BSA on PDADMAC,
ΘBSA/PDADMAC , for both series α and β are as follows: {ΘBSA/PDADMAC, « = 2.1 mg m" ; ΘBSA/PDADMAC, β = 2.7 mg m' ).
[0039] The surface loading for BSA on PDADMAC surface was calculated by dividing the average amount of BSA adsorbed per deposition cycle (obtained from Fig. 2) by the internal surface area of the PLLA porous templates.
[0040] It was advantageously recognized that protein/polyelectrolyte multilayers fabricated by the LBL self-assembly technique possess a permeable structure (ref 24). Consequently, selective solvent extraction was possible through the self-assembled layers allowing access and solubilization of the PLLA template.
[0041] Throughout the extraction process of the PLLA template, solvent and solubilized PLLA molecules are thus able to permeate through the self-assembled film.
[0042] The extraction of samples β is advantageously performed in methylene chloride. Porous and partially transparent structures without deformation or cracking are obtained. Substrate α is best extracted in a mixture of methylene chloride/ethanol. Gravimetric measurements show that virtually no residual PLLA is left in samples β after extraction while in the case of samples α, 0.4% of the initial mass of PLLA is still present.
[0043] Figure 3 demonstrates the morphology of both series through the preparation procedure. The effect of annealing (β) on the pore diameter after PCL extraction (Stage B) is illustrated in Figs. 3A and 3B. After LBL deposition and extraction of the PLLA (Figs. 3C and 3D), it can be seen that the pore size of the porous materials is similar to the phase size in the corresponding blend template. The microstructure generated is the replicate of the interface of the initial co-continuous polymer blend.
[0044] In some samples (α) the PLLA template was only partially extracted (Fig. 3E). To do so, an 8 hour extraction was performed instead of the usual 48 hours for a complete extraction.
[0045] Materials with significantly thicker walls, and hence better mechanical properties, are obtained by leaving a portion of the PLLA layer as an additional support of the final structure. This approach may also serve to control the void volume fraction of the network. A sheath longitudinal and cross section is clearly visible in Fig. 3E while Fig. 3F illustrates a typical nanosheath thickness of about 100 nm for substrate β. It is particularly clear on this figure that the nanosheaths are not fibrous. Indeed, it is clear on Figures 3D and 3F that the nanosheaths are not fibrous-like.
[0046] Figure 4 shows the properties of the structures for α and β at each stage of the process. The overall shape and approximate dimensions of the samples are preserved at any point of the procedure. The radial marks observed on the outer skin of the substrates are artifacts generated by the knife during the initial shaping process but are not present in the internal morphology.
[0047] A flowsorb 2300 BET instrument was used to measure the surface area of the samples. Thereby, the number average diameter (dn) is obtained from the volume/surface ratio (dn = 4V/S).
[0048] After stage B, the effect of annealing of the initial PLLA/PCL blend on the pore size can be seen. The phase growth observed during annealing decreases the interfacial surface area of the co-continuous blend and thus decreases the internal surface area available for deposition.
[0049] Still referring to Fig. 4, properties of the structures produced at each stage of the preparation process and corresponding scanning electron micrographs of series β are shown. Similar photomicrographs were obtained for series α.
[0050] Once the supporting PLLA template structure is removed, the assembled polyelectrolyte/protein layers take the form of very thin sheaths.
[0051] One of the main advantages of the method of the present invention is that deposition of self-assembled multilayers onto a PLLA template surface and subsequent extraction of that surface should yield a structure with twice the surface area per unit volume of the original porous blend. Considering experimental uncertainties, the ratio ξ, of the internal surface area per unit volume of the final structure (Stage D) to that at the
preceding Stage C, indicates that this is indeed observed for both the α and β series (ξa = 2.1 and ξβ = 1.7).
[0052] Finally, after stage D, substrate α possesses a void fraction of 98.7%, an internal surface area per unit volume of 2.3 μrrϊ1 and a specific surface area of 140 m2 g"1 while the annealed substrate β yields a void fraction of 99.6%, an internal surface area of 0.63 μm"1 and a specific surface area of 63 m2 g"1.
[0053] A sample preparation technique using a focused ion beam
(FIB) apparatus (ref 19) was used to prepare the porous materials for electron microscopy. This approach minimizes macroscopic deformation or collapse of the structure.
[0054] In accordance with the method of the present invention interconnected nanosheath network of ultra-high void fraction, high internal surface areas and uniform pore size were produced.
[0055] Advantageously, the method of the present invention is very versatile and high levels of control can be exercised over void fraction, surface area and pore size.
[0056] For example, virtually any polymer pair can be used to prepare the original co-continuous blend template. This potentially allows one to prepare such porous structures with pore sizes ranging from 100 nm to hundreds of microns.
[0057] In addition to that, a wide range of polymers can be self- assembled onto the template opening the door to a variety of potential uses including biomedical, catalysis and conductive polymer applications.
REFERENCES
1. A. G. Mikos et a/., J. Biomed. Mat. Res. 27, 183 (1993).
2. A. G. Mikos et a/., Polymer 35, 1068 (1994).
3. L. D. Harris, B. S. Kim, D. J. Mooney, J. Biomed. Mat. Res. 42, 396 (1998).
4. C. Schugens, V. Maquet, C. Grandfils, R. Jerome, P. Teyssie, J. Biomed. Mat. Res. 30, 449 (1996).
5. C. Schugens, V. Maquet, C. Grandfils, R. Jerome, P. Teyssie, Polymer 37, 1027 (1996).
6. T. Segura et ai, Biomaterials 26, 359 (2005).
7. P. Sarazin, X. Roy, B. D. Favis, Biomaterials 25, 5965 (2004).
8. P. Sarazin, B. D. Favis, Biomacromolecules 4, 1669 (2003).
9. Z. H. Yuan, B. D. Favis, Biomaterials 25, 2161 (2004).
10. Z. H. Yuan, B. D. Favis, AIChE J. 51 , 271 (2005).
11. G. Decher, J. D. Hong, J. Schmitt, Thin Solid Films 210, 831 (1992).
12. G. Decher, Science 277, 1232 (1997).
13. S. T. Dubas, J. B. Schlenoff, Macromolecules 32, 8153 (1999).
14. J. B. Schlenoff, S. T. Dubas, Macromolecules 34, 592 (2001 ).
15. E. Popotshev, B. Schoeler, F. Caruso, Langmuir 20, 829 (2004).
16. B. Schoeler, G. Kumaraswamy, F. Caruso, Macromolecules 35, 889 (2002).
17. F. Caruso, R. A. Caruso, H. Mohwald, Science 282, 1111 (1998).
18. E. Donath, G. B. Sukhorukov, F. Caruso, S. A. Davis, H. Mόhwald, Angew. Chem. Int. Ed. 37, 2201 (1998).
19. N. Virgilio, M. -F. Pepin, P. Desjardin, G. L'Esperance, B. D. Favis, Macromolecules 38, 2368 (2005).
20. Y. Lvov, K. Ariga, I. lchinose, T. Kunitake, J. Am. Chem. Soc. 117, 6117 (1995).
21. F. Caruso, H. Mohwald, J. Am. Chem. Soc. 121 , 6039 (1999).
22. N. A. Kotov, Nanostructured Materials 12, 789 (1999).
23. J. Kim, G. A. Somorjai, J. Am. Chem. Soc. 125, 3150 (2003).
24. F. Caruso, D. N. Furlong, K. Ariga, I. lchinose, T. Kunitake, Langmuir 14, 4559 (1998).
Claims
1. A method for making a porous material, said method comprising the steps of:
(a) melt-blending two or more non-miscible polymers to obtain a co-continuous melt;
(b) solidifying the melt of step (a) to obtain a solid mass;
(c) selectively extracting at least one of the polymers from said solid mass, thereby creating an essentially continuous pore network within said solid mass, said pore network having an internal surface;
(d) replicating the internal surface of the pore network within said solid mass by coating said internal surface with successive material layers; and
(e) selectively extracting said solid mass without extracting said layers, thereby producing a porous material.
2. The method of claim 1 wherein said material layers are polymeric layers.
3. The method of claim 2 wherein the last material layer contains functional chemical groups.
4. The method of claim 2 wherein at least some of said polymeric layers are conductive.
5. The method of claim 2 wherein said polymeric layers are conductive.
6. The method of claim 1 further comprising, after step (b), quiescent annealing of the solid mass obtained.
7. The method of claim 1 further comprising exchanging the solvent and freeze-drying the porous material.
8. The method of claim 1 further comprising, after step (c), depositing one or more precursor layers on the internal surface of said pore network.
9. The method of claim 8, wherein a first precursor layer comprises poly(diallyldimethylarnmonium chloride), a second precursor layer comprises poly(sodium 4-styrenesulfonate), and a third precursor layer comprises poly(diallyldimethylammonium chloride).
10. The method of claim 1 wherein in step (e), the extraction is partial so as to provide the porous material within a partially extracted solid mass.
11. The method of claim 1 wherein in step (e), the extraction is total.
12. The method of claim 1 wherein in step (d), one or more of the successive layers comprises poly(diallyldimethylammonium chloride).
13. The method of claim 1 wherein in step (d), one or more of the successive layers comprises proteins, cell growth promoters, functionalizing agents or mixture thereof.
14. The method of claim 1 wherein in step (d), about half of the successive layers comprises a mixture of bovine serum albumin and poly(diallyldimethylammonium chloride) and wherein about half of the successive layers comprises bovine serum albumin and are essentially free of poly(diallyldimethylammonium chloride).
15. The method of claim 1 wherein in step (a), the non-miscible polymers are poly(L-lactic acid) and poly(ε-caprolactone).
16. The method of claim 1 wherein step in (a) is performed at about 2000C.
17. The method of claim 1 , comprising after step (c), depositing precursor layers on the internal surface of said pore network, said precursor layers consisting of a first precursor layer comprising poly(diallyldimethylammonium chloride), a second precursor layer comprising poly(sodium 4-styrenesulfonate), and a third precursor layer comprising poly(diallyldimethylammonium chloride).
18. The method of claim 1 wherein in step (d), half of the successive layers comprises a mixture of bovine serum albumin and poly(diallyldimethylammonium chloride) and wherein about half of the successive layers comprises bovine serum albumin and are essentially free of poly(diallyldimethylammonium chloride).
19. A porous material manufactured using the method of claim 1.
20. A porous material having a void fraction higher than about 75% and mainly consisting of essentially fully interconnected sheath-like non- spherical pores and essentially non-fibrous walls.
21. The porous material of claim 20 having a void fraction higher than about 90%.
22. The porous material of claim 20 having a void fraction ranging from 98.7% to 99.6%.
23. The porous material of claim 20-22 having average pore wall thickness of about 100 nanometers.
24. The porous material of claim 20-23 having a specific surface area of about 0.4 to about 140 m2 /gram.
25. The porous material of claim 20-24 having an internal surface area per unit volume of about 0.29 to about 2.3 μm"1.
26. The use of the porous material of claim 19 in tissue engineering.
27. The use of the porous materials of claim 20-25 in tissue engineering.
28. The use of the porous material of claim 19 as a substrate for controlled release applications.
29. The use of the porous materials of claim 20-25 as a substrate for controlled release applications.
30. The use of the porous material of claim 19 as an implantable medical device.
31. The use of the porous materials of claim 20-25 as an implantable medical device.
32. The use of the porous material of claim 19 as separation sieve in separation systems.
33. The use of the porous materials of claims 20-25 as separation sieve in separation systems.
34. The use of the porous material of claim 19 in catalysis.
35. The use of the porous materials of claims 20-25 in catalysis.
36. The use of the porous material of claim 19 in conductivity applications.
37. The use of the porous materials of claims 20-25 in conductivity applications.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/093,712 US8257624B2 (en) | 2005-11-14 | 2006-11-14 | Porous nanosheath networks, method of making and uses thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73589005P | 2005-11-14 | 2005-11-14 | |
US60/735,890 | 2005-11-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007053955A1 true WO2007053955A1 (en) | 2007-05-18 |
Family
ID=38022942
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CA2006/001852 WO2007053955A1 (en) | 2005-11-14 | 2006-11-14 | Porous nanosheath networks, method of making and uses thereof |
Country Status (2)
Country | Link |
---|---|
US (1) | US8257624B2 (en) |
WO (1) | WO2007053955A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2179751A1 (en) * | 2008-10-21 | 2010-04-28 | Stichting Dutch Polymer Institute | Macroporous polymeric crosslinked materials, method for manufacture thereof and use |
WO2011107803A1 (en) * | 2010-03-05 | 2011-09-09 | Invibio Limited | Polymeric materials |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9452001B2 (en) * | 2005-02-22 | 2016-09-27 | Tecres S.P.A. | Disposable device for treatment of infections of human limbs |
US8313527B2 (en) | 2007-11-05 | 2012-11-20 | Allergan, Inc. | Soft prosthesis shell texturing method |
US8506627B2 (en) | 2008-08-13 | 2013-08-13 | Allergan, Inc. | Soft filled prosthesis shell with discrete fixation surfaces |
US9050184B2 (en) | 2008-08-13 | 2015-06-09 | Allergan, Inc. | Dual plane breast implant |
AU2010249028A1 (en) * | 2009-05-13 | 2011-12-08 | Allergan, Inc. | Implants and methods for manufacturing same |
US20110093069A1 (en) * | 2009-10-16 | 2011-04-21 | Allergan, Inc. | Implants and methdos for manufacturing same |
AU2011209793A1 (en) * | 2010-01-28 | 2012-08-16 | Allergan, Inc. | Open celled silicone foams, implants including them and processes for making same |
US20110196488A1 (en) * | 2010-02-03 | 2011-08-11 | Allergan, Inc. | Degradation resistant implantable materials and methods |
US9044897B2 (en) | 2010-09-28 | 2015-06-02 | Allergan, Inc. | Porous materials, methods of making and uses |
US8877822B2 (en) | 2010-09-28 | 2014-11-04 | Allergan, Inc. | Porogen compositions, methods of making and uses |
US9138308B2 (en) | 2010-02-03 | 2015-09-22 | Apollo Endosurgery, Inc. | Mucosal tissue adhesion via textured surface |
US9072821B2 (en) | 2010-02-05 | 2015-07-07 | Allergan, Inc. | Biocompatible structures and compositions |
US8889751B2 (en) | 2010-09-28 | 2014-11-18 | Allergan, Inc. | Porous materials, methods of making and uses |
US9205577B2 (en) | 2010-02-05 | 2015-12-08 | Allergan, Inc. | Porogen compositions, methods of making and uses |
US9138309B2 (en) | 2010-02-05 | 2015-09-22 | Allergan, Inc. | Porous materials, methods of making and uses |
CA2797691A1 (en) | 2010-04-27 | 2011-11-03 | Alexei Goraltchouk | Foam-like materials and methods for producing same |
AU2011252010A1 (en) * | 2010-05-10 | 2012-12-20 | Allergan, Inc. | Porous materials, methods of making and uses |
EP2571543B1 (en) * | 2010-05-11 | 2018-12-05 | Allergan, Inc. | Porous materials, methods of making and uses |
US11202853B2 (en) | 2010-05-11 | 2021-12-21 | Allergan, Inc. | Porogen compositions, methods of making and uses |
ES2623475T3 (en) | 2010-05-11 | 2017-07-11 | Allergan, Inc. | Porogen compositions, methods for making them and uses |
US8679279B2 (en) | 2010-11-16 | 2014-03-25 | Allergan, Inc. | Methods for creating foam-like texture |
US8546458B2 (en) | 2010-12-07 | 2013-10-01 | Allergan, Inc. | Process for texturing materials |
US8801782B2 (en) | 2011-12-15 | 2014-08-12 | Allergan, Inc. | Surgical methods for breast reconstruction or augmentation |
WO2014022657A1 (en) | 2012-08-02 | 2014-02-06 | Allergan, Inc. | Mucosal tissue adhesion via textured surface |
EP2900289A1 (en) | 2012-09-28 | 2015-08-05 | Allergan, Inc. | Porogen compositions, methods of making and uses |
CA2895083A1 (en) | 2012-12-13 | 2014-06-19 | Allergan, Inc. | Device and method for making a variable surface breast implant |
US20160200891A1 (en) * | 2013-08-22 | 2016-07-14 | Polyvalor Limited Partnership | Porous gels and methods for their preparation |
CA2949231A1 (en) | 2014-05-16 | 2015-11-19 | Allergan, Inc. | Soft filled prosthesis shell with variable texture |
US10092392B2 (en) | 2014-05-16 | 2018-10-09 | Allergan, Inc. | Textured breast implant and methods of making same |
EP3090862A1 (en) * | 2015-05-07 | 2016-11-09 | Christian-Albrechts-Universität zu Kiel | Microporous hydrogels |
CN111836678A (en) * | 2018-03-15 | 2020-10-27 | 东丽株式会社 | Fluid separation membrane |
KR102106363B1 (en) * | 2019-01-28 | 2020-05-06 | 한국과학기술원 | Method of manufacturing porous structure |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6673285B2 (en) * | 2000-05-12 | 2004-01-06 | The Regents Of The University Of Michigan | Reverse fabrication of porous materials |
CA2512072A1 (en) * | 2003-01-03 | 2004-07-29 | Biomerix Corporation | Reticulated elastomeric matrices, their manufacture and use in implantable devices |
US6929764B2 (en) * | 2000-11-17 | 2005-08-16 | William Marsh Rice University | Polymers having ordered, monodisperse pores and their corresponding ordered, monodisperse colloids |
WO2006059984A1 (en) * | 2004-11-30 | 2006-06-08 | The Regents Of The University Of Michigan | Modified porous materials and method of forming the same |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5502092A (en) * | 1994-02-18 | 1996-03-26 | Minnesota Mining And Manufacturing Company | Biocompatible porous matrix of bioabsorbable material |
-
2006
- 2006-11-14 US US12/093,712 patent/US8257624B2/en active Active
- 2006-11-14 WO PCT/CA2006/001852 patent/WO2007053955A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6673285B2 (en) * | 2000-05-12 | 2004-01-06 | The Regents Of The University Of Michigan | Reverse fabrication of porous materials |
US6929764B2 (en) * | 2000-11-17 | 2005-08-16 | William Marsh Rice University | Polymers having ordered, monodisperse pores and their corresponding ordered, monodisperse colloids |
CA2512072A1 (en) * | 2003-01-03 | 2004-07-29 | Biomerix Corporation | Reticulated elastomeric matrices, their manufacture and use in implantable devices |
WO2006059984A1 (en) * | 2004-11-30 | 2006-06-08 | The Regents Of The University Of Michigan | Modified porous materials and method of forming the same |
Non-Patent Citations (4)
Title |
---|
DECHER: "Fuzzy nanoassemblies: toward layered polymeric multicomposites", SCIENCE, vol. 277, 1997, pages 1232 - 1237 * |
LIU ET AL.: "Surface engineering of nano-fibrous poly(L-lactic acid) scaffolds via self-assembly technique for bone tissue engineering", J. BIOMED. NANOTECH., vol. 1/1, 2005, pages 54 - 60 * |
ROY ET AL.: "Ultraporous nanosheath materials by layer-by-layer deposition onto co-continuous polymer-blend templates", ADV. MATER., vol. 18/8, 2006, pages 1015 - 1019 * |
SARAZIN: "Controlled preparation and properties of porous poly(L-lactide) obtained from a co-continuous blend of two biodegradable polymers", BIOMATERIALS, vol. 25/28, 2004, pages 5965 - 5978 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2179751A1 (en) * | 2008-10-21 | 2010-04-28 | Stichting Dutch Polymer Institute | Macroporous polymeric crosslinked materials, method for manufacture thereof and use |
WO2010046084A1 (en) * | 2008-10-21 | 2010-04-29 | Stichting Dutch Polymer Institute | Macroporous polymeric crosslinked materials, method for manufacture thereof and use |
WO2011107803A1 (en) * | 2010-03-05 | 2011-09-09 | Invibio Limited | Polymeric materials |
Also Published As
Publication number | Publication date |
---|---|
US20090087641A1 (en) | 2009-04-02 |
US8257624B2 (en) | 2012-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8257624B2 (en) | Porous nanosheath networks, method of making and uses thereof | |
Hester et al. | Design and performance of foul-resistant poly (vinylidene fluoride) membranes prepared in a single-step by surface segregation | |
KR101854481B1 (en) | Porogen compositions, methods of making and uses | |
Formica et al. | A bioinspired ultraporous nanofiber‐hydrogel mimic of the cartilage extracellular matrix | |
US20070036844A1 (en) | Porous materials having multi-size geometries | |
Tanaka et al. | Design of novel biointerfaces (II). Fabrication of self‐organized porous polymer film with highly uniform pores | |
Kee et al. | Permeability performance of different molecular weight cellulose acetate hemodialysis membrane | |
US7323208B2 (en) | Modified porous materials and method of forming the same | |
Yu et al. | Novel thin-film nanofibrous composite membranes containing directional toxin transport nanochannels for efficient and safe hemodialysis application | |
Shi et al. | Selective swelling of electrospun block copolymers: from perforated nanofibers to high flux and responsive ultrafiltration membranes | |
US7182894B2 (en) | Process for the preparation of free standing membranes | |
US7993738B2 (en) | Modified porous materials and method of forming the same | |
JP2017196613A (en) | Dialysis membrane and manufacturing method thereof | |
CN109922839B (en) | Immunity isolation film, chamber for transplantation and device for transplantation | |
Cardea et al. | Supercritical phase inversion to form drug-loaded poly (vinylidene fluoride-co-hexafluoropropylene) membranes | |
Zhang et al. | Dual‐functional electrospun poly (2‐hydroxyethyl methacrylate) | |
Xiang et al. | Controlling burst and final drug release times from porous polylactide devices derived from co-continuous polymer blends | |
KR101712862B1 (en) | Porous polymer micro-beads, method for preparing thereof, and bio materials using the same | |
Li et al. | Preparation of Sodium Carboxymethyl Cellulose–Chitosan Complex Membranes through Sustainable Aqueous Phase Separation | |
WO2017126612A1 (en) | Semipermeable membrane and production method therefor | |
WO2005063365A1 (en) | A process for the preparation of free standing membranes | |
Salehi et al. | Porous devices derived from co-continuous polymer blends as a route for controlled drug release | |
Akgönüllü et al. | Versatile polymeric cryogels and their biomedical applications | |
Lee et al. | Biphasic release characteristics of dual drug-loaded alginate beads | |
EP1099468A2 (en) | Microporous hydrophilic membrane |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12093712 Country of ref document: US |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06804722 Country of ref document: EP Kind code of ref document: A1 |